Skip to content

Beta-1,4 N-acetylgalactosaminyltransferase 2 (B4GALNT2)

Homo sapiens — UniProt Q8NHY0

Gene: B4GALNT2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Beta-1,4 N-acetylgalactosaminyltransferase 2 (B4GALNT2) is a protein from Homo sapiens identified by UniProt accession Q8NHY0, 566 residues long. MolForge cross-references it against 0 known binders and 76 disease associations.

  • UniProt accession: Q8NHY0; gene symbol B4GALNT2.
  • Organism: Homo sapiens.
  • Length: 566 amino acids.
  • Top disease associations (Open Targets): neutrophil count, HMG CoA reductase inhibitor use measurement and Calcium channel blocker use measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameBeta-1,4 N-acetylgalactosaminyltransferase 2
UniProt accessionQ8NHY0
GeneB4GALNT2
OrganismHomo sapiens
Length566 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (76)

Diseases linked to this target (Open Targets).

  • neutrophil count · score 0.24
  • HMG CoA reductase inhibitor use measurement · score 0.22
  • Calcium channel blocker use measurement · score 0.22
  • leukocyte count · score 0.22
  • Agents acting on the renin-angiotensin system use measurement · score 0.21
  • monocyte percentage of leukocytes · score 0.17
  • age at onset · score 0.16
  • Myopia · score 0.16
  • refractive error · score 0.16
  • sex hormone-binding globulin measurement · score 0.13

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8NHY0-F1alphafoldPREDICTED83.83—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8NHY0.

Amino-acid sequence (566 residues)

MGSAGFSVGK FHVEVASRGR ECVSGTPECG NRLGSAGFGA LCLELRGADP AWGPFAAHGR SRRQGSRFLW LLKILVIILV LGIVGFMFGS MFLQAVFSSP KPELPSPAPG VQKLKLLPEE RLRNLFSYDG IWLFPKNQCK CEANKEQGGY NFQDAYGQSD LPAVKARRQA EFEHFQRREG LPRPLPLLVQ PNLPFGYPVH GVEVMPLHTV PIPGLQFEGP DAPVYEVTLT ASLGTLNTLA DVPDSVVQGR GQKQLIISTS DRKLLKFILQ HVTYTSTGYQ HQKVDIVSLE SRSSVAKFPV TIRHPVIPKL YDPGPERKLR NLVTIATKTF LRPHKLMIML RSIREYYPDL TVIVADDSQK PLEIKDNHVE YYTMPFGKGW FAGRNLAISQ VTTKYVLWVD DDFLFNEETK IEVLVDVLEK TELDVVGGSV LGNVFQFKLL LEQSENGACL HKRMGFFQPL DGFPSCVVTS GVVNFFLAHT ERLQRVGFDP RLQRVAHSEF FIDGLGTLLV GSCPEVIIGH QSRSPVVDSE LAALEKTYNT YRSNTLTRVQ FKLALHYFKN HLQCAA

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with B4GALNT2?

The strongest Open Targets associations for B4GALNT2 are neutrophil count, HMG CoA reductase inhibitor use measurement, Calcium channel blocker use measurement, leukocyte count and Agents acting on the renin-angiotensin system use measurement.

How long is the B4GALNT2 protein?

The Homo sapiens B4GALNT2 protein (UniProt Q8NHY0) is 566 amino acids long.

Browse: Targets: B · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Beta-1,4 N-acetylgalactosaminyltransferase 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8NHY0
GeneB4GALNT2
OrganismHomo sapiens
Length566
Binders0
Diseases76
View on UniProt